Two major Michigan hospitals have joined a nationwide study of closed-head traumatic brain injuries (TBIs) in the hopes of finding better ways to diagnose and treat these often disabling or life-threatening conditions, according to a recent article at MLive.com.
Both St. Mary’s of Michigan in Saginaw and Bronson Methodist Hospital in Kalamazoo have joined the study, which will examine whether doses of the hormone progesterone decrease swelling after traumatic brain injuries. If the hormone proves to be effective, it may greatly improve the chances of survival and recovery after a TBI-causing accident, according to researchers.
Progesterone is a hormone that naturally occurs in the human brain, where it is produced by the brain’s glial cells. Since progesterone plays a role in regulating the menstrual cycle, it’s usually present in larger amounts in women than in men, but bodies of both sexes produce the hormone.
Currently, no medications are approved by the U.S. Food and Drug Administration (FDA) to treat the specific type of brain swelling that occurs after a TBI. If progesterone shows efficacy in treating this type of swelling, the FDA may approve its use in TBI treatments – a significant step forward for TBI patients, say researchers.
Traumatic brain injuries can occur in any type of accident, and even a mild TBI can cause long-term impairment. If you’ve suffered a head injury, call the dedicated personal injury lawyers in Southfield at Lipton Law today. Our number is (248) 557-1688 – call us for a free and confidential consultation.